Campos Sandra Yvette
Known title: DirectorCIK: 0001865087
Associated companies
Transaction History
| PETS | ▼ Sell | Open Market | 58,898 | $195K | 4/30/2025 | View on chart |
| PETS | ▼ Sell | Open Market | 1,565 | $5K | 4/30/2025 | View on chart |
| PETS | ▲ Buy | Grant | 146,772 | $0 | 1/15/2025 | View on chart |
| PETS | ▲ Buy | Grant | 483,092 | $0 | 4/29/2024 | View on chart |
| PETS | ▲ Buy | Grant | 7,500 | $0 | 8/3/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Morgan Stanley Lowers PETS Target to $1.40
Morgan Stanley has kept its underweight view on PETS but cut its price target to $1.40. The rating signals the firm expects the stock to trade below its current level. With the RSI near 19, the shares are in oversold territory and near a support level of $1.96. This downgrade may influence investor sentiment.
Morgan Stanley Lowers PETS Target to $1.40. Morgan Stanley has kept its underweight view on PETS but cut its price target to $1.40. The rating signals the firm expects the stock to trade below its current level. With the RSI near 19, the shares are in oversold territory and near a support level of $1.96. This downgrade may influence investor sentiment.